For investors looking for solid ground in an uncertain market, balance sheet is king

For investors looking for solid ground in an uncertain market, balance sheet is king


Google headquarters in Mountain View, California, US, on Monday, Jan. 30, 2023. Alphabet Inc. is expected to release earnings figures on February 2.

Marlena Sloss | Bloomberg | Getty Images

Amid ongoing market volatility and renewed fears about the health of the banking sector, investors and analysts are increasingly targeting the stocks of companies with stellar balance sheets. Eleven Club holdings stand out, with chipmaker Nvidia (NVDA) and Google parent Alphabet (GOOGL) leading the pack.



Source

Study links talc use to ovarian cancer — a potential boon for thousands suing J&J
Health

Study links talc use to ovarian cancer — a potential boon for thousands suing J&J

In this photo illustration a bottle of Johnson & Johnson baby powder is displayed on a table on November 12, 2021 in San Anselmo, California. Justin Sullivan | Getty Images New research published this week lends credence to the more than 50,000 lawsuits against Johnson & Johnson that allege its talc-based baby powder caused ovarian cancer. The analysis, […]

Read More
FDA approves Amgen’s treatment for most deadly form of lung cancer 
Health

FDA approves Amgen’s treatment for most deadly form of lung cancer 

The Amgen headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | Getty Images The Food and Drug Administration on Thursday approved Amgen‘s therapy for patients with the most deadly form of lung cancer.  The agency cleared the drug, which will be marketed under the name Imdelltra, as a second or later line of treatment […]

Read More
Roche says weight loss drug shows promising results in early trial
Health

Roche says weight loss drug shows promising results in early trial

A logo at the Roche Holding AG headquarters in Basel, Switzerland, on Thursday, Feb. 1, 2024. Bloomberg | Getty Images Roche on Thursday said its experimental weight loss drug showed promising results in an early-stage trial, boosting the company’s bid to compete in the booming market for those treatments. The Swiss company joined a slate of […]

Read More